Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1984 1
1985 1
1986 5
1987 8
1988 10
1989 11
1990 15
1991 13
1992 20
1993 31
1994 33
1995 32
1996 33
1997 33
1998 50
1999 31
2000 44
2001 51
2002 54
2003 50
2004 74
2005 63
2006 72
2007 61
2008 82
2009 69
2010 68
2011 80
2012 75
2013 84
2014 77
2015 73
2016 78
2017 72
2018 72
2019 85
2020 74
Text availability
Article attribute
Article type
Publication date

Search Results

1,663 results
Results by year
Filters applied: . Clear all
Page 1
Probiotics in Inflammatory Bowel Disease.
Abraham BP, Quigley EMM. Abraham BP, et al. Gastroenterol Clin North Am. 2017 Dec;46(4):769-782. doi: 10.1016/j.gtc.2017.08.003. Epub 2017 Oct 3. Gastroenterol Clin North Am. 2017. PMID: 29173520 Review.
However, thought there is some evidence for efficacy in ulcerative colitis and in pouchitis, in particular, there has been little indication that probiotics exert any benefit in Crohn disease. ...
However, thought there is some evidence for efficacy in ulcerative colitis and in pouchitis, in particular, there has been little ind …
Management of Pouchitis and Other Common Complications of the Pouch.
Dalal RL, Shen B, Schwartz DA. Dalal RL, et al. Inflamm Bowel Dis. 2018 Apr 23;24(5):989-996. doi: 10.1093/ibd/izy020. Inflamm Bowel Dis. 2018. PMID: 29688472 Review.
Pouchitis is the most common complication of this procedure and can occur in about 50% of patients. Treatment of pouchitis depends on the phenotype of disease. Pouchitis can be classified as acute, chronic/refractory, or secondary pouchitis, which incl
Pouchitis is the most common complication of this procedure and can occur in about 50% of patients. Treatment of pouchitis dep
Diversion colitis and pouchitis: A mini-review.
Tominaga K, Kamimura K, Takahashi K, Yokoyama J, Yamagiwa S, Terai S. Tominaga K, et al. World J Gastroenterol. 2018 Apr 28;24(16):1734-1747. doi: 10.3748/wjg.v24.i16.1734. World J Gastroenterol. 2018. PMID: 29713128 Free PMC article. Review.
Similar to diversion colitis, diversion pouchitis is an inflammatory disorder occurring in the ileal pouch, resulting from the exclusion of the fecal stream and a subsequent lack of nutrients from luminal bacteria. ...We are hopeful that the information summarized here will …
Similar to diversion colitis, diversion pouchitis is an inflammatory disorder occurring in the ileal pouch, resulting from the exclusi …
Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence.
Hata K, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Tanaka T, Kishikawa J, Anzai H, Watanabe T. Hata K, et al. Dig Endosc. 2017 Jan;29(1):26-34. doi: 10.1111/den.12744. Epub 2016 Nov 7. Dig Endosc. 2017. PMID: 27681447 Review.
The reported incidence of pouchitis ranges from 14% to 59%, and antibiotic therapy is the primary treatment for acute pouchitis. Chronic pouchitis includes antibiotic-dependent and refractory pouchitis. Intensive therapy including antitumor necrosis fa …
The reported incidence of pouchitis ranges from 14% to 59%, and antibiotic therapy is the primary treatment for acute pouchitis
Inflammatory pouch disease: The spectrum of pouchitis.
Zezos P, Saibil F. Zezos P, et al. World J Gastroenterol. 2015 Aug 7;21(29):8739-52. doi: 10.3748/wjg.v21.i29.8739. World J Gastroenterol. 2015. PMID: 26269664 Free PMC article. Review.
Based on the etiology we can sub-divide pouchitis into 2 groups: idiopathic and secondary. In idiopathic pouchitis the etiology and pathogenesis are still unclear, while in secondary pouchitis there is an association with a specific causative or pathogenetic …
Based on the etiology we can sub-divide pouchitis into 2 groups: idiopathic and secondary. In idiopathic pouchitis the etiolog …
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Nguyen N, Zhang B, Holubar SD, Pardi DS, Singh S. Nguyen N, et al. Cochrane Database Syst Rev. 2019 Nov 30;11(11):CD001176. doi: 10.1002/14651858.CD001176.pub5. Cochrane Database Syst Rev. 2019. PMID: 31785173
The primary outcome was clinical improvement or remission in participants with acute or chronic pouchitis, or the proportion of participants with no episodes of pouchitis after IPAA. ...Four studies assessed treatment of acute pouchitis. Five studies assessed …
The primary outcome was clinical improvement or remission in participants with acute or chronic pouchitis, or the proportion of parti …
Ileal-anal pouches: A review of its history, indications, and complications.
Ng KS, Gonsalves SJ, Sagar PM. Ng KS, et al. World J Gastroenterol. 2019 Aug 21;25(31):4320-4342. doi: 10.3748/wjg.v25.i31.4320. World J Gastroenterol. 2019. PMID: 31496616 Free PMC article. Review.
Pouchitis is a common cause that remains incompletely understood and difficult to manage at times. 10% of patients succumb to the diagnosis of pouch failure, which is traditionally associated with the need for pouch excision. ...
Pouchitis is a common cause that remains incompletely understood and difficult to manage at times. 10% of patients succumb to the dia
A Comprehensive Approach to Pouch Disorders.
Quinn KP, Lightner AL, Faubion WA, Raffals LE. Quinn KP, et al. Inflamm Bowel Dis. 2019 Feb 21;25(3):460-471. doi: 10.1093/ibd/izy267. Inflamm Bowel Dis. 2019. PMID: 30124882 Review.
Although pouchitis is the most well-recognized and frequent complication after IPAA, a number of additional inflammatory, postsurgical, structural, neoplastic, and functional complications may occur, resulting in pouch dysfunction. ...
Although pouchitis is the most well-recognized and frequent complication after IPAA, a number of additional inflammatory, postsurgica …
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm.
Segal JP, Ding NS, Worley G, Mclaughlin S, Preston S, Faiz OD, Clark SK, Hart AL. Segal JP, et al. Aliment Pharmacol Ther. 2017 Mar;45(5):581-592. doi: 10.1111/apt.13905. Epub 2016 Dec 23. Aliment Pharmacol Ther. 2017. PMID: 28008631 Free article. Review.
The incidence of pouchitis is 40% at 5 years. Ten to 15% of patients with pouchitis experience chronic pouchitis. AIM: To determine the efficacy of medical therapies for the treatment of chronic refractory pouchitis in patients undergoing IPAA for UC. …
The incidence of pouchitis is 40% at 5 years. Ten to 15% of patients with pouchitis experience chronic pouchitis. AIM: …
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.
Barreiro-de Acosta M, Gutierrez A, Rodríguez-Lago I, Espín E, Ferrer Bradley I, Marín-Jimenez I, Beltrán B, Chaparro M, Gisbert JP, Nos P; en representación de GETECCU. Barreiro-de Acosta M, et al. Gastroenterol Hepatol. 2019 Nov;42(9):568-578. doi: 10.1016/j.gastrohep.2019.08.001. Epub 2019 Oct 9. Gastroenterol Hepatol. 2019. PMID: 31606162 Free article. English, Spanish.
The recommended index to assess its activity is the Pouchitis Disease Activity Index (PDAI), but its modified version (PDAIm) can be used in clinical practice. In accordance with the duration of symptoms, pouchitis can be classified as acute (<4 weeks) or chronic …
The recommended index to assess its activity is the Pouchitis Disease Activity Index (PDAI), but its modified version (PDAIm) can be …
1,663 results
Jump to page
Feedback